|
Cephalexin impurity 3
|
頭孢氨芐雜質(zhì) 3
|
|
|
Pramipexole Related Impurity 2
|
普拉克索雜質(zhì)標(biāo)準(zhǔn)品
|
|
|
Moxifloxacin impurities
|
莫西沙星系列雜質(zhì)
|
|
|
Moxifloxacin impurities
|
莫西沙星雜質(zhì)
|
1394029-14-1
|
|
Formyl ciprofloxacin
|
甲酰環(huán)丙沙星雜質(zhì)
|
93594-39-9
|
|
Amifostine impurity3
|
氨磷汀雜質(zhì)3
|
|
|
(S)-2,2'-(2-methyl-6-oxopiperazine-1,4-diyl)diacetic acid
|
右雷佐生雜質(zhì)21
|
|
|
ethyl 2-formyl-3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate
|
莫西沙星雜質(zhì)JX
|
|
|
Amifostine impurity 1
|
氨磷汀雜質(zhì)1
|
|
|
Gadobutrol Impurity 4
|
釓布醇雜質(zhì)4
|
|
|
Gadobutrol Impurity 3
|
釓布醇雜質(zhì)3
|
|
|
Cediranib
|
西地尼布
|
288383-20-0
|
|
Levofloxacin, chloromethyl ester impurity
|
左氧氟沙星氯代甲酯雜質(zhì)
|
|
|
Poziotinib
|
波齊替尼
|
1092364-38-9
|
|
Afatinib
|
阿法替尼(BIBW 2992)
|
439081-18-2
|
|
Cabozantinib Malate
|
蘋果酸卡博替尼（CABOZANTINIB S-MALATE）
|
1140909-48-3
|
|
regorafenib
|
瑞格非尼
|
755037-03-7
|
|
Crizotinib
|
克唑替尼
|
877399-52-5
|
|
Cediranib Maleate
|
西地尼布馬來酸鹽
|
857036-77-2
|
|
Cephalexin impurity 5
|
頭孢氨芐雜質(zhì) 5
|
1323247-65-9
|
|
Cephalexin S-Sulfoxide
|
CEPHALEXIN S-SULFOXIDE
|
74708-55-7
|
|
Cephalexin 7-Epimer
|
頭孢氨芐 7-差向異構(gòu)體
|
|
|
Cephalexin impurity 6
|
頭孢氨芐雜質(zhì) 6
|
72820-16-7
|
|
Cephalexin R-Sulfoxide
|
苯甘孢霉素亞砜
|
52210-38-5
|
|
Lauratinib
|
勞拉替尼（PF0643922）
|
1454846-35-5
|
|
Pramipexole Related Impurity 1
|
普拉克索二聚體雜質(zhì)
|
1244656-98-1
|
|
Entrectinib
|
恩曲替尼
|
1108743-60-7
|
|
Moxifloxacin Impurity 45
|
莫西沙星雜質(zhì)45
|
|
|
Niraparib tosylate
|
尼拉帕尼對甲苯磺酸鹽
|
1613220-15-7
|
|
Finasteride
|
非那雄胺
|
98319-26-7
|
|
Bosutinib
|
博舒替尼
|
380843-75-4
|
|
Vandetanib
|
凡德他尼
|
443913-73-3
|
|
AZD3759
|
奧希替尼
|
1626387-80-1
|
|
alectinib
|
艾樂替尼
|
1256580-46-7
|
|
axitinib
|
阿昔替尼
|
319460-85-0
|
|
Olaparib
|
奧拉帕尼
|
763113-22-0
|
|
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4,6-trione
|
6-氧代-5,6-二氫尿苷
|
19556-63-9
|
|
ThiametGDiscontinued
|
THIAMET G
|
1009816-48-1
|
|
SB204741
|
SB 204741
|
152239-46-8
|
|
1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-a-D-glucopyranoseHydrochloride
|
1,3,4,6-四-O-乙?；?2-氨基-ALPHA-D-吡喃葡萄糖鹽酸鹽
|
10034-19-2
|
|
treosulfan
|
曲奧舒凡
|
299-75-2
|
|
Geranyl
|
(2R,3R,4S,5S,6R)-2-[(2E)-3,7-二甲基辛-2,6-二烯氧基]-6-[[(2S,3R,4S,5R)-3,4,5-三羥基四氫吡喃-2-基]氧基甲基]四氫吡喃-3,4,5-三醇
|
150995-11-2
|
|
9-ALPHA-RIBOFURANOSYLADENINE
|
ALPHA-腺苷
|
5682-25-7
|
|
2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranose
|
Β-D-氨基半乳糖五乙酸酯
|
3006-60-8
|
|
2-(Acetylamino)-2-deoxy-1-thio-alpha-D-glucopyranose
|
2-(乙酰氨基)-2-脫氧-1-硫代-ALPHA-D-吡喃葡萄糖
|
781581-10-0
|
|
Trametinib
|
曲美替尼
|
871700-17-3
|
|
lenvatinib Mesylate
|
樂伐替尼
|
857890-39-2
|
|
CapMatinib
|
苯扎米特
|
1029712-80-8
|
|
Nintedanib Ethanesulfonate Salt
|
尼達(dá)尼布乙磺酸鹽
|
656247-18-6
|
|
INCB28060
|
苯扎米特鹽酸鹽
|
1197376-85-4
|
|
Neratinib
|
來那替尼
|
698387-09-6
|
|
LOXO-101
|
拉羅替尼
|
1223405-08-0
|
|
Regorafenib hydrate
|
瑞格非尼一水合物
|
1019206-88-2
|
|
Pazopanib
|
帕唑帕尼
|
444731-52-6
|
|
Upadacitinib
|
烏帕替尼
|
1310726-60-3
|
|
Selumetinib
|
司美替尼
|
606143-52-6
|
|
Brigatinib
|
布格替尼
|
1197953-54-0
|
|
Dabrafenib
|
達(dá)帕菲尼
|
1195765-45-7
|
|
Dacomitinib
|
達(dá)克替尼
|
1110813-31-4
|
|
Prostaglandin E1
|
前列腺素E1
|
745-65-3
|
|
Bimatoprost
|
比馬前列素
|
155206-00-1
|
|
AP 32788
|
莫博替尼
|
1847461-43-1
|
|
Pramipexole Impurity 22
|
普拉克索雜質(zhì)22
|
|
|
Pramipexole Impurity 16
|
普拉克索雜質(zhì)16
|
1373869-91-0
|
|
rac-7-Oxo-Pramipexole HCl
|
普拉克索雜質(zhì)29
|
1286047-33-3
|
|
Decarboxy Moxifloxacin
|
脫羧酸莫西沙星
|
929102-25-0
|
|
(2S,4S)-Argatroban
|
(2S,4S)-阿加曲班
|
189264-03-7
|
|
Benazepril Related Compound F
|
貝那普利雜質(zhì)F
|
109010-60-8
|
|
Nicorandil EP Impurity C
|
尼可地爾雜質(zhì)C
|
88598-33-8
|
|
Nicorandil EP Impurity D
|
尼可地爾雜質(zhì)D
|
40055-37-6
|
|
Dibucaine Impurity C
|
辛可卡因EP雜質(zhì)C
|
87864-08-2
|
|
Nicorandil EP Impurity A
|
尼可地爾EP雜質(zhì)A
|
65141-47-1
|
|
Nicorandil EP Impurity B
|
尼可地爾EP雜質(zhì)B
|
6265-73-2
|
|
Nicorandil Impurity 6
|
尼可地爾雜質(zhì)6
|
|
|
Nicorandil Dimer Bromide
|
尼可地爾二聚體
|
2250142-73-3
|
|
N-(5-(3-(2-ethoxyphenyl)-3-oxopropanoyl)-1-methyl-3-propyl-1H-pyrazol-4-yl)-2-hydroxybenzamide
|
西地那非雜質(zhì)36
|
|
|
R- Dexrazoxane
|
R-右雷佐生
|
24613-06-7
|
|
Gadobutrol Impurity 2
|
釓布醇雜質(zhì)2
|
|
|
Gadobutrol Impurity 5
|
釓布醇雜質(zhì)5
|
114873-37-9
|
|
gadolinium(III) 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetat
|
釓布醇雜質(zhì)32
|
|
|
(3S,4S)-2-Oxa-8-azaspiro[4.5]decan-4-amine, 3-methyl-, hydrochloride (1:2)
|
(3S,4S)-3-甲基-2-氧雜-8-氮雜螺[4.5]癸-4-胺二鹽酸鹽
|
2055761-19-6
|
|
ectoine
|
四氫嘧啶
|
96702-03-3
|
|
2-Pyrazinemethanol
|
RMC-4550
|
2172651-73-7
|
|
(3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine 2,2,2-trifluoroacetate
|
(3S,4S)-8-(6-氨基-5-((2-氨基-3-氯吡啶基-4-基)硫代)吡嗪-2-基)-3-甲基-2-氧雜-8-氮雜螺[4.5]癸-4-胺
|
1801765-04-7
|
|
Gadobutrol Impurity 23
|
釓布醇雜質(zhì)23
|
|
|
Gadobutrol Impurity 11
|
釓布醇雜質(zhì)11
|
|
|
4-(hydroxyamino)-N-(2-(naphthalen-2-yloxy)ethyl)-N- ((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) benzenesulfonamide
|
N-BETA-D-吡喃葡萄糖基-4-(羥基氨基)-N-[2-(2-萘基氧基)乙基]-苯磺酰胺
|
188480-51-5
|
|
(2-chloro-5-iodophenyl)(2-ethoxyphenyl)methanone
|
達(dá)格列凈雜質(zhì)8
|
2305949-33-9
|
|
1-chloro-2-(2-ethoxybenzyl)-4-iodobenzene
|
達(dá)格列凈雜質(zhì)9
|
2305949-36-2
|
|
ethyl 3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate
|
莫西沙星SM2雜質(zhì)
|
112811-68-4
|
|
α-L-galactose
|
L-(-)-半乳糖
|
15572-79-9
|
|
((Z)-ethyl 3-ethoxy-2-(2,4,5-trifluoro-3-methoxybenzoyl)acrylate)
|
莫西沙星雜質(zhì)Ⅳ
|
866954-86-1
|
|
Benazepril impurity
|
貝那普利雜質(zhì)
|
1347874-67-2
|
|
7(4H)-Benzothiazolone, 2-amino-5,6-dihydro-6-(propylamino)-, (6S)-
|
普拉克索雜質(zhì)
|
2204518-89-6
|
|
3,4-DI-O-ACETYL-6-DEOXY-L-GLUCAL
|
二-O-乙?；?L-鼠李醛
|
34819-86-8
|
|
2-(2-NAPHTHYLOXY)ETHANAMINE
|
2-(2-萘氧基)乙胺
|
23314-24-1
|
|
Cephalexin impurity L
|
頭孢氨芐雜質(zhì) L
|
34632-04-7
|
|
3-[(2-Hydroxyethyl)amino]propiononitrile
|
氨磷汀雜質(zhì)4
|
33759-44-3
|
|
Amifostine impurity2
|
氨磷汀雜質(zhì)2
|
6305-56-2
|